@CR_UK Clinical Trials Unit @unibirmingham is one of largest UK units running phase I-III adult & paediatric trials including @CRCTU_Haem_Team @crctuASCENTteam
University of Birmingham
Joined February 2013
- Tweets2.1K
- Following568
- Followers2K
- Likes2.3K
Birmingham Cancer Research UK Clinical Trials Unit retweeted
#BloodCancerAwarenessMonth | The @unibirmingham AMMO study is testing a new tablet treatment for rare blood cancers called MDS/MPN overlap syndromes. It could offer a simpler, more effective option than current injection treatment, helping improve symptoms. @bloodcancer_uk @CRCTU
ALT A person's hand with three white circular tablets in the palm.
Birmingham Cancer Research UK Clinical Trials Unit retweeted
✨New Paper✨
Is mTORC1/2 inhibition effective in STK11 deficient NSCLC? (Arm B2, National Lung Matrix Trial)
Real pleasure working with this fab team, key mentions: @CindyBillingham, @joshsavage, @adbeggs,@CRCTU, (Gary Middleton, not on twitter)
nature.com/articles/s41698-0…
very proud to see that the 2025 @BTOGORG Lifetime Achievement Award was presented to our very own Professor of Biostatistics @CindyBillingham for her contributions to thoracic oncology clinical trials 🏆🫁👩🔬 @unibirm_CMH @unibirmingham #BTOG25 – at Birmingham, England
We are delighted to announce that the 2025 BTOG Lifetime Achievement Award has been presented to Professor @CindyBillingham.
The announcement was made by Professor Gary MIddleton with a heartfelt speech and hosted at the 23nd BTOG Annual Conference in Belfast by Professor @DrSanjayPopat. Professor Billingham received several well-deserved standing ovations.
Each year BTOG gives a lifetime achievement award to an individual who in the steering committee’s opinion has made a significant contribution to the management of thoracic malignancies in the UK.
#BTOG25 #LCSM
Birmingham Cancer Research UK Clinical Trials Unit retweeted
🌟Lucinda Billingham Receives the 2025 @BTOGORG Lifetime Achievement Award🏆
@CindyBillingham
The British Thoracic Oncology Group (BTOG) has awarded Lucinda Billingham the 2025 BTOG Lifetime Achievement Award for her contributions to thoracic oncology in the UK.🫁 The award was presented by Professor Gary Middleton at the 23rd BTOG Annual Conference in Belfast.🎗️
💡This prestigious award recognizes individuals who have made a lasting impact on the field of thoracic oncology, shaping the future of cancer care and research. BTOG continues to honor those whose dedication has advanced the management of thoracic malignancies in the UK and beyond.🌍
oncodaily.com/career/lucinda…
#Cancer #CancerResearch #BTOG2025 #Medicine #LungCancer #LCSM #MedX #MedEd #MedNews #Health #Oncology #OncoDaily
Birmingham Cancer Research UK Clinical Trials Unit retweeted
We are delighted to announce that the 2025 BTOG Lifetime Achievement Award has been presented to Professor @CindyBillingham.
The announcement was made by Professor Gary MIddleton with a heartfelt speech and hosted at the 23nd BTOG Annual Conference in Belfast by Professor @DrSanjayPopat. Professor Billingham received several well-deserved standing ovations.
Each year BTOG gives a lifetime achievement award to an individual who in the steering committee’s opinion has made a significant contribution to the management of thoracic malignancies in the UK.
#BTOG25 #LCSM
We have just published the #BladderPath #ClinicalTrial results have just been published in @JCO_ASCO ascopubs.org/doi/full/10.120…
Thank you to all the participants and research teams for their contributions and support
@Prof_Nick_James @Actionbladderca @NIHRresearch
Birmingham Cancer Research UK Clinical Trials Unit retweeted
The first sites for a new global trial to find a cure for rare childhood cancer, have opened.
The trial, run by this University, will look at multiple new treatments & offer better chance of survival for hundreds of young people around world.
Find out more birmingham.ac.uk/news/2024/g…
ALT Young child in the arms of a nurse
Birmingham Cancer Research UK Clinical Trials Unit retweeted
Global trial opens for those who have not responded to treatment for BNHL, a rare childhood cancer.
The @CRCTU at @unibirmingham is leading a trial to test multiple new treatments & offer better chance of survival for hundreds of young people worldwide. birmingham.ac.uk/news/2024/g…
Birmingham Cancer Research UK Clinical Trials Unit retweeted
A global clinical trial - led by @unibirmingham and supported by the PHTA Industry Trials Hub - has opened for recruitment in the UK. Glo-BNHL will test multiple treatments for children with the rare cancer B-cell Non-Hodgkin Lymphoma >
phta.co.uk/global-trial-find… @CRCTU
new #clinicaltrial to improve treatment of the rare bone cancer #EwingSarcoma aims to recruit 900 patients in UK, Europe & Australasia by 2032. #INTEREWING1 is funded by @CRUKresearch and led by Prof. Brennan @MFTnhs birmingham.ac.uk/news/2024/n… @euroewing @unibirm_CMH @unibirmingham – at Birmingham, England
600th patient has entered #rEECur #ClinicalTrial; largest randomised trial in recurrent/refractory #EwingSarcoma. rEECur collected data on 5 widely used chemotherapies and is now assessing a 6th targeted drug. Thanks to our funders, clinicians & patients @euroewing @CRUKresearch – at Birmingham, England
Birmingham Cancer Research UK Clinical Trials Unit retweeted
The Haem Team @CRCTU are proud to manage STELLAR which is a landmark Richters Syndrome trial recruiting at 16 sites in the UK. Delighted to hear news about a patient in remission! @tobyeyre82 @AnnaSchuh3 Thanks to @BloodCancer_Res and @AstraZeneca itv.com/news/granada/2024-09…
Birmingham Cancer Research UK Clinical Trials Unit retweeted
#ClinicalTrial Glo-BNHL run through Birmingham paediatric ECMC is looking to find better medicines for children & young people with relapsed or refractory B-cell Non-Hodgkin’s #Lymphoma 👉bit.ly/3Ausz3r #CCAM
stories like Aleesha-Marie's remind us #WhyWeDoResearch @CRCTU. #MyeChild01 is just 1 of our groundbreaking & life-changing clinical trials that we deliver @unibirmingham, thanks to the support of @CRUKresearch and our NHS & international colleagues #ChildhoodCancerAwarenessMonth – at Birmingham, England
Aleesha-Marie joined our MyeChild01 #ClinicalTrial after she was diagnosed with acute myeloid #Leukaemia 💛
Now she's starting university and hopes to become a paediatric nurse. Read her story and find out about the trial 👇
#CRUKYoungPeople #ChildhoodCancerAwarenessMonth
we recently published the results of #AmyotrophicLateralSclerosis (#ALS) trial in @PLOSONE. This showed that long-term weekly low-molecular weight dextran sulphate injections were well tolerated and safe in ALS patients @Bach_Surgeon @unibirmingham #MND birmingham.ac.uk/news/2024/s… – at Birmingham, England
Birmingham Cancer Research UK Clinical Trials Unit retweeted
The first patient has been recruited to the FARGO clinical trial, which is testing the potential of faecal microbiota transplantation (#FMT) to treat patients living with primary sclerosing cholangitis (#PSC), a rare liver disease.
birminghambrc.nihr.ac.uk/new…
@CholestasisDoc
ALT Picture of trial lead Dr Palak Trivedi, with quote: "We are very excited to have our first patient joining this innovative trial. There is currently no cure or medication for primary sclerosing cholangitis, and this is the first time worldwide that FMT treatment is being investigated for patients with the disease."
Birmingham Cancer Research UK Clinical Trials Unit retweeted
Delighted to announce that the Protocol for the @
@Petneck2 trial is now published in BMC Cancer
@BMC_series. The trial is open across 31 sites and has recruited 293 patients! @PaulNankivell, @h_mehanna,
@CRCTU
rdcu.be/dNoK3
#MITHRIDATE #clinicaltrial of #ruxolitinib vs current best available treatment for #polycythaemiavera, has recently randomised its 150th UK patient. We're also delighted that the 1st French 🇫🇷 patient has been recruited cancerresearchuk.org/about-c… @MPNVoice @Institut_cancer @Novartis
Birmingham Cancer Research UK Clinical Trials Unit retweeted
We're hearing from keynote lecturer Amos Burke (Birmingham paediatric ECMC & @CRCTU) this morning, discussing #ClinicalTrials during the innovating young SIOPE session.
@unibirmingham | @IcgsUob | #SIOPEurope2024
Birmingham Cancer Research UK Clinical Trials Unit retweeted
"The Covid booster programme has been shown to have an important protective effect for many of the most clinically vulnerable members of society for whom the initial two doses were insufficient" from the OCTAVE DUO study birmingham.ac.uk/news/2024/t… @kearns_pam @CRCTU @unibirm_MDS